Low-density lipoprotein cholesterol goal attainment in Germany: Results from the DA VINCI study.

Gouni-Berthold, Ioanna; Schaper, Frank; Schatz, Ulrike; Tabbert-Zitzler, Anja; Fraass, Uwe; Sauer, Sarah; Ray, Kausik K

Gouni-Berthold, Ioanna; Schaper, Frank; Schatz, Ulrike; Tabbert-Zitzler, Anja; Fraass, Uwe; Sauer, Sarah; Ray, Kausik K.

Afiliação

Gouni-Berthold I; University of Cologne, Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
Schaper F; Diabetology Clinic, Dresden, Germany.
Schatz U; University Hospital "Carl Gustav Carus", Technische Universität, Dresden, Germany.
Tabbert-Zitzler A; Amgen Germany GmbH, Munich, Germany.
Fraass U; Amgen Germany GmbH, Munich, Germany.
Sauer S; Amgen Germany GmbH, Munich, Germany.
Ray KK; Imperial Centre for Cardiovascular Disease Prevention and Imperial Clinical Trials Unit, Imperial College, London, UK.

Atheroscler Plus ; 50: 10-16, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36643801

Palavras-chave

Cardiovascular risk; Cholesterol; Da Vinci; Dyslipidaemia; Goal attainment; Guidelines; Statins

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Atheroscler Plus Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google